Anika Therapeutics | ANIK - Passivo Circulante

Preço das Ações
14.97
Mudança Diária
0.21 1.42%
Mensal
4.25%
Anual
7.78%
Q2 Previsão
14.36




Passivo Circulante Alterar Data
Abbott USD 16.5B 1.91B 2025-12
Agenus USD 323.49M 36.36M 2025-12
Agios Pharmaceuticals USD 82.21M 7.45M 2025-12
Anika Therapeutics USD 21.91M 2.82M 2025-12
Arrowhead Research USD 347.42M 151.94M 2025-12
Enanta Pharmaceuticals USD 44.73M 3.83M 2025-12
Halozyme Therapeutics USD 177.09M 660.14M 2025-12
Heron Therapeutics USD 96.1M 6.39M 2025-12
Insmed USD 468.87M 51.66M 2025-12
Integra LifeSciences USD 455.98M 91.93M 2025-12
Intrexon USD 23.02M 38K 2024-06
J&J USD 54.13B 3.26B 2025-12
Karyopharm Therapeutics USD 92.06M 4.9M 2025-12
Ligand Pharmaceuticals USD 37.45M 6.91M 2025-12
MacroGenics USD 43.11M 1.36M 2025-12
Merit Medical Systems USD 239.76M 9.29M 2025-12
Rigel Pharmaceuticals USD 94.4M 7.76M 2025-09
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sanofi EUR 28.35B 3.76B 2025-12
Smith & Nephew USD 1.54B 236M 2025-12
Stryker USD 7.79B 380M 2025-12
Surmodics USD 19.44M 1.1M 2025-06
Veracyte USD 59.94M 12.22M 2025-12
Xencor USD 95.91M 9.42M 2025-12
Zimmer Biomet Holdings USD 2.58B 180.8M 2025-12